Purchase Order 75N91022P00405

This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS), to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The $149,800 contract is for Somalogic to expand on previous traumatic brain injury (TBI) studies using the latest SomaScan 7K protein biomarker assay on both female and male mouse models.

Somalogic is a commercial-stage proteomics company that has received over $6 million in prior prime contract awards from HHS agencies, including NIH, FDA, and VA, to provide its SomaScan assay services for proteomic research and clinical trials. Additionally, the company has performed over $1 million in subcontract work sequencing plasma samples, and received $3 million in subawards under federal grants to conduct proteomic analysis of biospecimens. Somalogic also holds a $4 million indefinite delivery contract with the FDA for its SomaScan proteomics services.